profit from every R$100 of sales.
R$0R$100
Raia Drogasil
R$14.29+0.21% today
-25.6% in 1 year
1-year low R$14.261-year high R$27.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay R$19.27 for every R$1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Raia Drogasil sold, what it kept, and what it did with the cash.
Sales went from R$29.1 billion in 2022 to R$44.3 billion in 2025, with R$1.30 billion of profit last year.
SalesProfit
Raia Drogasil vs. similar companies
Raia Drogasil grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from R$100 of sales | Sales growth a year | Price per R$1 of profit |
|---|---|---|---|
| Raia Drogasil | 19.3× · Fair price | ||
 JD Health International | 20.5× · Fair price | ||
 Tsuruha Holdings | 26.6× · Fair price | ||
 MatsukiyoCocokara & | 19.7× · Fair price | ||
 Yifeng Pharmacy Chain | 18.4× · Fair price |
AI analysis
An AI analyst reads Raia Drogasil's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 29,067 | 33,974 | 38,872 | 44,250 | |
| 8,809 | 10,207 | 11,557 | 12,965 | |
| 1,866 | 1,953 | 2,370 | 2,649 | |
| 2,453 | 2,752 | 3,144 | 3,563 | |
| 996 | 1,055 | 1,200 | 1,297 | |
| 0.59 | 0.63 | 0.71 | 0.78 | |
| 30.3% | 30.0% | 29.7% | 29.3% | |
| 6.4% | 5.7% | 6.1% | 6.0% | |
| 3.4% | 3.1% | 3.1% | 2.9% |
Balance sheet
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17,185 | 20,094 | 22,164 | 25,170 |
| Cash | 434 | 412 | 528 | 510 |
| Total debt | 6,058 | 7,067 | 7,718 | 8,834 |
| Total liabilities | 11,782 | 14,066 | 15,717 | 17,835 |
| 5,341 | 5,956 | 6,433 | 7,322 | |
| 1,687 | 1,663 | 1,688 | 1,659 | |
| 10.1% | 9.9% | 10.4% | 10.3% | |
| 18.7% | 17.7% | 18.7% | 17.7% |
Cash flow
| In millions of BRL | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 839 | 963 | 1,913 | 1,509 | |
| 1,189 | 1,305 | 1,284 | 1,403 | |
| -349 | -342 | 629 | 106 | |
| Dividends paid | – | – | – | – |
| 0 | 0 | 73 | 0 | |
| 23 | 33 | 38 | 28 |
Valuation
- 19.3×
- –
- 1.96
- 3.7×
- 0.6×
- 234.6×
- 9.3×
- 0.4%
- 5.2%
- –
Profitability
- 29.3%
- 6.0%
- 2.9%
- –
- 10.3%
- 10.2%
- –
- –
- –
- –
Growth
- +15.0%
- +9.8%
- –
- –
- −1.9%
Financial health
- 2.3×
- 1.21
- –
- 2.4×
- 1.46
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 28%of 952
Bottom 39%of 884
Top 33%of 601
Top 36%of 886
Bottom 43%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
39No pass
Benjamin Graham
48No pass
Philip Fisher
43No pass
Peter Lynch
42No pass
Joel Greenblatt
38No pass
Charlie Munger
29No pass
Terry Smith
24No pass
Questions about Raia Drogasil
Is Raia Drogasil a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Raia Drogasil AI analysis
What does Raia Drogasil do?
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. It is in Pharmaceutical Retailers, based in São Paulo, SP, Brazil, with 75,190 employees.
Is Raia Drogasil stock halal?
No. Raia Drogasil does not pass our halal screen: its debt is 35% of its market value, at or above the 33% limit. How we check
How has Raia Drogasil stock done over the past year?
Down 25.6% over the past twelve months, to R$14.29. It traded between R$14.26 and R$27.00 and is 47.1% below its high.
Who are Raia Drogasil's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Yifeng Pharmacy Chain. The peers table on this page compares their profit, growth and price with Raia Drogasil's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.